Aileron Therapeutics, Inc. (ALRN)
Total Valuation
ALRN has a market cap or net worth of $9.28 million. The enterprise value is -$2.81 million.
| Market Cap | 9.28M |
| Enterprise Value | -2.81M |
Important Dates
The last earnings date was Friday, October 13, 2023, after market close.
| Earnings Date | Oct 13, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ALRN has 4.89 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Shares Outstanding | 4.89M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 9.03% |
| Owned by Institutions (%) | 23.19% |
| Float | 3.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.83 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.88, with zero debt.
| Current Ratio | 7.88 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -91.00% and return on invested capital (ROIC) is -122.25%.
| Return on Equity (ROE) | -91.00% |
| Return on Assets (ROA) | -78.50% |
| Return on Capital (ROIC) | -122.25% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.16M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.00% in the last 52 weeks. The beta is 2.14, so ALRN's price volatility has been higher than the market average.
| Beta (1Y) | 2.14 |
| 52-Week Price Change | -35.00% |
| 50-Day Moving Average | 1.47 |
| 200-Day Moving Average | 1.58 |
| Relative Strength Index (RSI) | 61.10 |
| Average Volume (30 Days) | 47,331 |
Short Selling Information
The latest short interest is 77,224, so 1.58% of the outstanding shares have been sold short.
| Short Interest | 77,224 |
| Short Previous Month | 3,851 |
| Short % of Shares Out | 1.58% |
| Short % of Float | 2.29% |
| Short Ratio (days to cover) | 0.74 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.69M |
| Pretax Income | -12.94M |
| Net Income | -12.94M |
| EBITDA | -12.83M |
| EBIT | -12.94M |
| Earnings Per Share (EPS) | -$2.86 |
Balance Sheet
The company has $12.09 million in cash and no debt, giving a net cash position of $12.09 million or $2.48 per share.
| Cash & Cash Equivalents | 12.09M |
| Total Debt | n/a |
| Net Cash | 12.09M |
| Net Cash Per Share | $2.48 |
| Equity / Book Value | 11.20M |
| Book Value Per Share | 2.29 |
| Working Capital | 11.17M |
Cash Flow
In the last 12 months, operating cash flow was -$13.83 million and capital expenditures $42,000, giving a free cash flow of -$13.78 million.
| Operating Cash Flow | -13.83M |
| Capital Expenditures | 42,000 |
| Free Cash Flow | -13.78M |
| FCF Per Share | -$3.04 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -139.40% |
| FCF Yield | -148.49% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.00% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 11, 2022. It was a reverse split with a ratio of 1:20.
| Last Split Date | Nov 11, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |